Lopressor/adverse reactions: Difference between revisions

Jump to navigation Jump to search
← Older edit
VisualWikitext
Gerald Chi (talk | contribs)
CMEAdmin, Bureaucrats, bureaucrats, editnews, exportpages, interwiki, nocaptcha, nukepages, smwadministrator, Administrators, Widget editors
17,702 edits
m Gerald Chi moved page Metoprolol adverse reactions to Lopressor adverse reactions without leaving a redirect
GeraldChi (talk | contribs)
Bureaucrats, bureaucrats, nocaptcha, Administrators
8,887 edits
 
(10 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
#REDIRECT [[Metoprolol tartrate#Adverse Reactions]]
{{Metoprolol}}
{{CMG}}
 
==Adverse Reactions==
 
====Hypertension and Angina====
 
Most adverse effects have been mild and transient.
 
<u>'''Central Nervous System'''</u>: [[Tiredness]] and [[dizziness]] have occurred in about 10 of 100 patients. [[Depression]] has been reported in about 5 of 100 patients. Mental [[confusion]] and short-term [[memory loss]] have been reported. [[Headache]], [[nightmares]], and [[insomnia]] have also been reported.
 
<u>'''Cardiovascular'''</u>: [[Shortness of breath]] and [[bradycardia]] have occurred in approximately 3 of 100 patients. Cold extremities; [[arterial insufficiency]], usually of the [[Raynaud phenomenon|Raynaud]] type; [[palpitations]]; [[congestive heart failure]]; [[peripheral edema]]; and [[hypotension]] have been reported in about 1 of 100 patients. [[Gangrene]]in patients with pre-existing severe peripheral circulatory disorders has also been reported very rarely. (See CONTRAINDICATIONS, WARNINGS, and PRECAUTIONS.)
 
<u>'''Respiratory'''</u>: [[Wheezing]] ([[bronchospasm]]) and [[dyspnea]] have been reported in about 1 of 100 patients (see WARNINGS). [[Rhinitis]] has also been reported.
 
<u>'''Gastrointestinal'''</u>: [[Diarrhea]] has occurred in about 5 of 100 patients. [[Nausea]], [[dry mouth]], [[gastric pain]], [[constipation]], [[flatulence]], and [[heartburn]] have been reported in about 1 of 100 patients. [[Vomiting]] was a common occurrence. Postmarketing experience reveals very rare reports of [[hepatitis]], [[jaundice]] and non-specific hepatic dysfunction. Isolated cases of [[transaminase]], [[alkaline phosphatase]], and [[lactic dehydrogenase]] elevations have also been reported.
 
<u>'''Hypersensitive Reactions'''</u>: [[Pruritus]] or [[rash]] have occurred in about 5 of 100 patients. Very rarely, [[photosensitivity]] and worsening of [[psoriasis]] has been reported.
 
<u>'''Miscellaneous'''</u>: [[Peyronie’s disease]] has been reported in fewer than 1 of 100,000 patients. Musculoskeletal pain, [[blurred vision]], and [[tinnitus]] have also been reported.
 
There have been rare reports of reversible [[alopecia]], [[agranulocytosis]], and [[dry eyes]]. Discontinuation of the drug should be considered if any such reaction is not otherwise explicable.
 
There have been very rare reports of weight gain, [[arthritis]], and [[retroperitoneal fibrosis]] (relationship to Lopressor has not been definitely established).
 
The [[oculomucocutaneous syndrome]] associated with the [[beta blocker]] [[practolol]] has not been reported with Lopressor.
 
====Myocardial Infarction====
 
<u>'''Central Nervous System'''</u>: [[Tiredness]] has been reported in about 1 of 100 patients. [[Vertigo]], [[sleep disturbance]]s, [[hallucinations]], [[headache]], [[dizziness]], [[visual disturbance]]s, [[confusion]], and [[reduced libido]] have also been reported, but a drug relationship is not clear.
 
<u>'''Cardiovascular'''</u>: In the randomized comparison of Lopressor and placebo described in the CLINICAL PHARMACOLOGY section, the following adverse reactions were reported:
 
{|
| [[File:Metop002.png|800px|thumb]]
|}
 
<u>'''Respiratory'''</u>: [[Dyspnea]] of pulmonary origin has been reported in fewer than 1 of 100 patients.
 
<u>'''Gastrointestinal'''</u>: [[Nausea]] and [[abdominal pain]] have been reported in fewer than 1 of 100 patients.
 
<u>'''Dermatologic'''</u>: [[Rash]] and worsened [[psoriasis]] have been reported, but a drug relationship is not clear.
 
<u>'''Miscellaneous'''</u>: Unstable [[diabetes]] and [[claudication]] have been reported, but a drug relationship is not clear.
 
====Potential Adverse Reactions====
 
A variety of adverse reactions not listed above have been reported with other [[beta-adrenergic blocking agents]] and should be considered potential adverse reactions to Lopressor.
 
<u>'''Central Nervous System'''</u>: Reversible mental [[depression]] progressing to [[catatonia]]; an acute reversible syndrome characterized by [[disorientation]] for time and place, short-term [[memory loss]], [[emotional lability]], slightly [[clouded sensorium]], and decreased performance on neuropsychometrics.
 
<u>'''Cardiovascular'''</u>: Intensification of [[AV block]] (see CONTRAINDICATIONS).
 
<u>'''Hematologic'''</u>: [[Agranulocytosis]], nonthrombocytopenic [[purpura]], and [[thrombocytopenic purpura]].
 
<u>'''Hypersensitive Reactions'''</u>: [[Fever]] combined with [[aching]] and [[sore throat]], [[laryngospasm]] and [[respiratory distress]].
 
====Postmarketing Experience====
 
The following adverse reactions have been reported during postapproval use of Lopressor: [[confusion|confusional state]], an increase in blood [[triglycerides]] and a decrease in [[HDL|High Density Lipoprotein (HDL)]]. Because these reports are from a population of uncertain size and are subject to confounding factors, it is not possible to reliably estimate their frequency.<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = LOPRESSOR (METOPROLOL TARTRATE) TABLET [NOVARTIS PHARMACEUTICALS CORPORATION] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bb05420c-fd24-4672-9f62-fdd313819287 | publisher =  | date =  | accessdate = }}</ref>
 
==References==
 
{{Reflist}}
 
{{FDA}}
 
[[Category:Drugs]]
[[Category:Cardiovascular Drugs]]
[[Category:Beta blockers]]

Latest revision as of 03:48, 22 July 2014

Redirect to:

Retrieved from "https://www.wikidoc.org/index.php?title=Lopressor/adverse_reactions&oldid=998873"